Overactive Bladder Treatment Market to Grow at 2.9% CAGR to 2022

The global overactive bladder treatment market is estimated to grow at a CAGR of 2.9% from 2017 to 2022, to reach USD 4.19 billion by 2022. The key factors driving the growth of this market include the rising prevalence of overactive bladder (OAB) coupled with the growing geriatric population and rising neurological disorders, namely, Parkinson’s Disease (PD), stroke, and multiple sclerosis (MS).

Click   Here   for   Complete   Report   on   Overactive   Bladder   Treatment   Market   spread  across 236 Pages, Profiling 15 Companies and Supported with 53 Tables and 39 Figures at http://www.rnrmarketresearch.com/overactive-bladder-treatment-market-by-pharmacotherapy-anticholinergic-solifenacin-oxybutynin-fesoterodine-darifenacin-mirabegron-botox-neurostimulation-disease-type-idiopathic-and-neurogenic-bladder-over-st-to-2022-market-report.html .

Overactive bladder (OAB) is a condition that is characterized by sudden, involuntary contraction of the muscle in the wall of the urinary bladder. This results in a sudden, compelling need to urinate that is difficult to suppress (urinary urgency), even though the bladder may only contain a small amount of urine. The key symptom is sudden urge to void (urgency) with or without urgency urinary incontinence, often associated with urinary frequency (voiding 8 or more times per day).

Introduction

1 Objective of the Study

2 Market Definition

3 Market Scope

4 Markets Covered

5 Years Considered in the Study

6 Currency

7 Limitations

8 Stakeholders

9 Assumptions

On the basis of pharmacotherapy, the overactive bladder treatment market is segmented into anticholinergics, mirabegron, BOTOX, and neurostimulation. The neurostimulation and BOTOX treatment segments are expected to witness the highest growth during the forecast period. The growth of these segments is mainly due to the higher efficacy and longevity of the treatment effects as compared to anticholinergics.

Click Here for Sample Papers of  Overactive  Bladder  Treatment  Market  with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1151258 .

Based on anticholinergic drugs, the overactive bladder treatment market is further classified into darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, trospium, and other anticholinergics (imidafenacin, emepronium, flavoxate, meladrazine, terodiline, propiverine, and desfesoterodine). Solifenacin is expected to command for the largest share of the global overactive bladder treatment market owing to its efficacy as compared to other drugs of its class.

Global Overactive Bladder Treatment Market, By Disease

1 Introduction

2 Idiopathic Overactive Bladder

3 Neurogenic Overactive Bladder

4 Introduction

5 Overactive Bladder in Parkinson’s Disease

6 Overactive Bladder in Stroke

7 Overactive Bladder in Multiple Sclerosis

8 Overactive Bladder in Spinal Cord Injury

9 Overactive Bladder in Other Disorders

Click Now for More Details on “Overactive Bladder Treatment Market by Pharmacotherapy (Anticholinergic- Solifenacin, Oxybutynin, Fesoterodine, Darifenacin; Mirabegron; BOTOX; Neurostimulation), Disease Type (Idiopathic and Neurogenic Bladder Overactivity) – Global Forecast to 2022”report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1151258 .

Break of primary participants was as mentioned below:

By Company Type – Tier 1–60%, Tier 2–25% and Tier 3–15%

By Designation – C-level–17%, Director Level–45%, Others–38%

By Region – North America–42%, Europe–28%, Asia-Pacific–17%, RoW–13%

The report analyzes the overactive bladder treatment market and aims at estimating the market size and future growth potential of this market based on various segments such as pharmacotherapy, disease type, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

List of Tables

1 Global Overactive Bladder Treatment Market, By Pharmacotherapy, 2015–2022 (USD Million)

2 Indicative List of Anticholinergics Used in OAB Treatment

3 Global Anticholinergics Market for Overactive Bladder Treatment, 2015–2022 (USD Million)

4 Global Anticholinergics Market for Overactive Bladder Treatment, By Country/Region, 2015–2022 (USD Million)

5 Solifenacin Market for Overactive Bladder Treatment, By Country/Region, 2015–2022 (USD Million)

6 Oxybutynin Market for Overactive Bladder Treatment, By Country/Region, 2015–2022 (USD Million)

Request for call back:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.